BioHarvest Sciences Inc.
BHST
$6.75
-$0.08-1.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.86% | 25.67% | 52.86% | -2.78% | -111.33% |
| Total Depreciation and Amortization | 36.06% | 51.01% | 71.56% | 48.93% | 37.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.09% | -57.48% | -92.20% | 126.11% | 751.09% |
| Change in Net Operating Assets | -66.95% | -117.07% | 86.09% | -173.51% | -167.09% |
| Cash from Operations | -1.02% | -7.75% | 22.64% | 21.57% | 9.25% |
| Capital Expenditure | 23.38% | 18.04% | -149.77% | -92.33% | -89.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.38% | 116.44% | -- | -- | -- |
| Cash from Investing | 28.14% | 25.71% | -164.02% | -105.36% | -101.80% |
| Total Debt Issued | 91.86% | 11.01% | -48.06% | -75.48% | -19.04% |
| Total Debt Repaid | -250.80% | -246.65% | -232.68% | -249.45% | -40.62% |
| Issuance of Common Stock | 23.24% | -100.00% | 1,035.82% | 1,075.68% | 1,072.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 56.14% | -38.51% | -21.87% | -49.99% | 29.13% |
| Foreign Exchange rate Adjustments | -149.38% | -175.29% | -144.87% | -157.63% | 723.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 578.08% | -142.94% | -101.12% | -181.93% | 269.57% |